The multi-centre trial evaluating FET-PET in Glioblastoma (FIG) trial, TROG 18:06, is the largest prospective international study of its kind addressing the role of FET-PET in the
management of pseudoprogression, prognostication and impact on adjuvant radiation planning.
An update will be provided regarding current recruitment status and timelines, as well as key learnings to date.